Table 1 Baseline characteristics

Age

(median, 1Q-3Q)

75 (67–81)

76 (71–81)

74 (65–81)

0.003*

Sex (%)

Male

Female

311 (67.32)

151 (32.68)

62 (55.36)

50 (44.64)

249 (71.14)

101 (28.86)

0.003*

CSDH side (%)

Both

Right

Left

78 (16.88)

183 (39.61)

201 (43.51)

24 (21.43)

50 (44.64)

38 (33.93)

54 (15.43)

133 (38.00)

163 (46.57)

0.049*

PAST HISTORY

HTN (%)

262 (56.71)

83 (74.11)

179 (51.14)

< 0.001*

DM (%)

140 (30.30)

51 (45.54)

89 (25.43)

< 0.001*

HL (%)

84 (18.18)

63 (56.25)

21 (6.00)

< 0.001*

LD (%)

28 (6.06)

7 (6.25)

21 (6.00)

1.000

KD (%)

24 (5.19)

4 (3.57)

20 (5.71)

0.469

CVA (%)

Ischemic

Hemorrhagic

Both

37 (8.01)

3 (0.06)

1 (0.22)

11 (9.82)

3 (2.68)

1 (0.89)

26 (7.43)

0 (0.00)

0 (0.00)

0.005*

CHD (%)

50 (10.82)

20 (17.86)

30 (8.57)

0.009*

Cancer (%)

31 (6.71)

4 (3.57)

27 (7.71)

0.191

HD (%)

10 (2.16)

1 (0.89)

9 (2.57)

0.463

LIPID PROFILE

TC

152.0 (131.2–178.0)

141.0 (117.5–161.5)

159.0 (137.5–187.5)

0.002*

HDL-C

47.00 (38.00–56.00)

47.00 (38.25–58.25)

46.00 (38.00–56.00)

0.508

LDL-C

87.00 (71.75–108.00)

72.00 (56.50–89.00)

92.00 (76.00–112.00)

< 0.001*

TG

94.0 (72.0–139.2)

97.5 (72.00–136.00)

96.5 (72.0–141.2)

0.140

COMPLICATIONS

Recurrence

74 (16.02)

15 (13.39)

60 (17.14)

0.381

Reoperation

62 (13.42)

12 (10.71)

50 (14.29)

0.426

Morbidity

15 (3.25)

4 (3.57)

11 (3.14)

0.767

Mortality

12 (2.60)

0 (0.00)

12 (3.43)

0.045*